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2174Objective: The purpose of the present study was to assess the efficacy of the long-term results after video-
assisted pulmonary vein isolation and left atrial appendage excision for lone atrial fibrillation (AF) and to deter-
mine the most significant risk factors for the long-term results.
Methods: From December 2006 to December 2012, 332 consecutive patients with lone AF underwent mini-
mally invasive surgical ablation at our center. Of the 332 patients, 91, who had undergone video-assisted
pulmonary vein isolation>5 years earlier, were evaluated in the present study (48 with paroxysmal AF, 21
with persistent AF, and 22 with long-standing persistent AF). The median follow-up period was 66 months.
The primary endpoint was the success rate of video-assisted pulmonary vein isolation, defined as the absence
of any atrial arrhythmia recurrence lasting>30 seconds at the clinical visit and on the electrocardiogram or
long-term cardiac rhythm recording after discharge.
Results: During the follow-up period, 1 patient (1.1%) experienced a stroke and 4 (4.4%) died of noncardiac
disease. At the 5-year follow-up point, 43 of 78 patients (55.1%) were in normal sinus rhythm. Of the 39 patients
with paroxysmal AF and 39 with nonparoxysmal AF, 27 (69.2%) and 16 (44.1%) were in normal sinus rhythm,
respectively. The results of the univariate and multivariate analyses of the preoperative risk factors for AF recur-
rence showed a left atrial diameter of 44 mm (hazard ratio, 5.56; 95% confidence interval, 1.68-18.387;
P ¼ .005) and an AF duration of 31.5 months (hazard ratio, 3.67; 95% confidence interval, 1.50-8.95;
P ¼ .004) were the most significant independent risk factors.
Conclusions: Patients with lone AF with a large preoperative left atrial diameter and long AF duration will not
be suitable for video-assisted pulmonary vein isolation alone and might need to undergo ablation of the lesions.
(J Thorac Cardiovasc Surg 2014;148:2174-80)Since Haissaguerre and colleagues1 reported that ectopic
beats originating in the pulmonary veins can result in the
spontaneous initiation of AF in 1998, concept development
in AF treatment has brought about changes in the technol-
ogy and methods of AF surgery. In 2005, Wolf and
colleagues2 performed video-assisted pulmonary vein
isolation (PVI) on 27 cases of lone AF (LAF) and reported
that 97% of the patients were free of AF at early follow-up.
Since then, a variety of minimally invasive surgical tech-
niques have been widely applied worldwide. The percent-
age of success with minimally invasive surgery for AF
has ranged from 42% to 95.5% in the published data,
with a follow-up period of 6 to 36 months.3-10 We
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The Journal of Thoracic and Cardiovascular Surundergone video-assisted PVI and left atrial appendage
(LAA) excision with>5 years of follow-up at our center,
representing one of the rare experiences with 5 years of
follow-up.METHODS
Patient Selection
From December 2006 to December 2012, 332 patients with LAF under-
went minimally invasive surgery at the Atrial Fibrillation Center, Beijing
Anzhen Hospital. The 91 patients who had undergone video-assisted PVI
5 years earlier were enrolled in the present study. The institutional review
board approved the research protocol, and all patients provided informed
consent before surgery.We classified all the patients as having either parox-
ysmal AF (PAF) or non-PAF. The non-PAF group included those with
persistent AF and longstanding, persistent AF. We followed the European
Society of Cardiology guidelines to score the AF-related symptoms (Euro-
pean Heart Rhythm Association score).11 Preoperative data were collected
for each patient enrolled in the present study, including preoperative AF
history, body mass index, and CHADS2 score. The patient characteristics
are listed in Table 1.
Preoperative Management
The patients underwent a detailed evaluation before surgery. Baseline
12-lead electrocardiographic (ECG) analysis, chest radiography, transtho-
racic ultrasound cardiography, transesophageal echocardiography, and
computed tomography coronary artery enhancement scanning or coronary
angiographic analysis were performed on admission. Also, all the patientsgery c November 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
AFL ¼ atrial flutter
CI ¼ confidence interval
ECG ¼ electrocardiographic
EP ¼ electrophysiologic
LAA ¼ left atrial appendage
LAD ¼ left atrial diameter
LAF ¼ lone AF
LVDd ¼ left ventricular end-diastolic dimension
LVEF ¼ LV ejection fraction
PAF ¼ paroxysmal AF
PV ¼ pulmonary vein
PVI ¼ PV isolation
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previous procedures, antiarrhythmic drug use, preoperative cerebrovascu-
lar adverse events, and so on.
Surgical Technique
We used the surgical technique we have previously reported.12 This
technique consisted of epicardial radiofrequency isolation of the bilateral
pulmonary vein (PV) antrum, excision of the LAA, division of the ligament
of Marshall, and electrophysiologic testing. Overall, bilateral PVI was per-
formed using an Isolator Transpolar ENDO ablation clamp (AtriCure,West
Chester, Ohio) and the Wolf Lumitip Dissector (AtriCure). LAA removal
was performed using the EZ-45 Endostapler (Johnson & Johnson Medical,
Inc, Arlington, Tex). The ligament of Marshall was cut under direct vision.
Intraoperative electrophysiologic testing was performed using 2 types of
sensing and pacing devices (Detect and Carelink 2090 programmer, Med-
tronic, Minneapolis, Minn). The procedure was performed using a 10-mm,
30 thoracoscope.Electrophysiologic Testing
Intraoperative electrophysiologic (EP) testing was performed in the lat-
est 30 consecutive patients (15 with PAF and 15 with persistent AF). EP
testing included the bilateral PV antrum and baseline and postisolation
sensing and pacing. A baseline positive sensing result (rapid and disorderly
atrial potentials) in the PVantrum area could be detected before PVI, and a
negative sensing result (no atrial potentials) could be detected in the same
area after PVI, which is termed an ‘‘entrance block.’’ A positive baseline
pacing result was defined as obtaining atrial and ventricular capture. ‘‘Cap-
ture’’ has been defined as the contraction of the atrium and ventricle in
response to the electrical stimulus sent from the temporary pacemaker. A
negative postablation pacing result would indicate that no capture was ob-
tained in the same area after ablation. A combined positive baseline pacing
and negative postablation pacing result has been termed ‘‘exit block.’’
Achieving both entrance and exit block has been regarded as a transmural
lesion blocking conduction in the PV antrum area.Postoperative Management
We have recommended that patients take amiodarone in small doses for
3 months postoperatively, with the medicine tapered off in the presence of a
stable sinus rhythm. A b-receptor blocking drug was used for patients intol-
erant to amiodarone. We have recommended that patients take a vitamin KThe Journal of Thoracic and Carantagonist for postoperative anticoagulation in the initial 3-month postop-
erative period. The international normalized ratio was required to be 2.0 to
3.0. After 3 months, the patients with AF recurrence or a CHADS2 score>2
points with NSR were recommended to take aspirin for anticoagulation.
During the follow-up period, direct-current cardioversion was recommen-
ded if the ECG analysis showed AF recurrence. Recurrent AF was defined
as AF, atrial flutter (AFL), or atrial tachycardia (AT) sustained for30 sec-
onds and occurring out of the postablation blanking period.13,14
Follow-up
Regular follow-up visits were scheduled at 3 and 6 months postopera-
tively and every year after discharge. At each visit, we offered the patients
free physical examinations, 12-lead ECG examinations, and 24- or 48-hour
Holter monitoring (Del Mar Reynolds Medical, Inc, Irvine, Calif). During
the follow-up period, the primary endpoint was defined as the absence of
AF and any atrial arrhythmia recurrence. In the present study, 63 of the
91 patients (69.2%) lived outside of Beijing. It was difficult for these pa-
tients to come to our center for each examination. We advised those who
could not come to our center to undergo the ECG and echocardiographic
examinations in their local city and to mail the results to us. If the patients
developed a relapse during the follow-up period, we enquired and recorded
the details of the recurrence.
Statistical Analysis
The patient characteristics and continuous variable data are presented as
the mean standard deviation or simple frequencies and percentages. The
outcomes of the rhythmswere descriptively analyzed at the follow-up inter-
vals. Also, according to the presence of postoperative AF recurrence during
the follow-up period, the patients were classified into 2 groups (nonrecur-
rence and recurrence). The AF-related risk factors for recurrence between
these 2 groups included gender, age, AF type, AF duration, left ventricular
end-diastolic dimension (LVDd), LV ejection fraction (LVEF), left atrial
diameter (LAD), and body mass index. These were included in the univar-
iate analysis using the t test or c2 test, according to the data type. Risk fac-
tors with P<.1 on univariate analysis were considered significant to avoid
missing more possibly meaningful variables and to relax the variable selec-
tion criteria. Receiver operating characteristic curves were used to deter-
mine the cutoff value for the continuous variables that were statistically
significant on univariate analysis. These continuous variables were classi-
fied into dummy variables according to their cutoff value, and their statis-
tically significant differences in each group were tested in Kaplan-Meier
curves. The Cox proportional hazards model was used to assessed the
risk factors (the dummy variables and the statistically significant categori-
cal variables on univariate analysis). The forward stepwise selection proce-
dure was used. Statistical analyses were performed using the Statistical
Package for Social Sciences, version 20.0 (SPSS, Chicago, Ill).RESULTS
Operative Results, Complications, and Mortality
The mean ablation time was 2.5 hours (range, 2.0-5.5).
Of the 91 patients, 75 (82.4%) were in normal sinus rhythm
(NSR) after surgery. Before ablation, 1 patient (1.1%)
underwent permanent pacemaker implantation because of
bradyarrhythmia and slow ventricular conduction. Also, 2
patients (2.2%) were found to have an unidentified smoke
shadow located in the LAA base on the transesophageal
echocardiogram preoperatively. To confirm the transeso-
phageal echocardiographic results, the 2 patients underwent
computed tomography. The computed tomography results
showed the smoke shadow was in a nonenhanced areadiovascular Surgery c Volume 148, Number 5 2175
TABLE 1. Baseline patient characteristics before ablation
Characteristic Results
Gender
Male 58
Female 33
Age (y) 58.0  9.8
AF type
PAF 48 (52.7)
Non-PAF 43 (47.3)
AF duration (mo) 70.4  58.8
Preoperative AAD use
b-Blocker 58 (63.7)
Amiodarone 50 (54.9)
Digoxin 20 (22.0)
LVEF* (%) 63.0  9.2
LVDd* (mm) 48.1  5.4
LADy (mm) 49.4  11.0
BMI (kg/m2) 25.8  5.6
Hypertension 32 (35.2)
Diabetes mellitus 4 (4.4)
Alcoholic history 14 (15.4)
Smoke history 17 (18.7)
Embolic events before ablation 7 (7.7)
Hyperthyroid 2 (2.2)
Preoperative permanent pacemaker implantation 1 (1.1)
Previous failed CA 2 (2.2)
LAA thrombus 2 (2.2)
NYHA class I-II 64 (70.3)
EHRA score III-IV 44 (48.4)
CHADS2 score<2 61 (67.0)
Data presented as mean  standard deviation or n (%). AF, Atrial fibrillation; PAF,
paroxysmal AF; ADD, antiarrhythmic drug; LVEF, left ventricular ejection fraction;
LVDd, left ventricular end-diastolic dimension; LAD, left atrial diameter; BMI, body
mass index;CA, catheter ablation; LAA, left atrial appendage;NYHA,NewYork Heart
Association; EHRA, European Heart Rhythm Association. *Data were collected for
87 patients. yLAD was measured in the parasternal long axis, indicating the left atrial
anteroposterior diameter.
Acquired Cardiovascular Disease Hu et al
A
C
Dwith a well-defined margin in the LAA. The distance be-
tween the nonenhanced area to the orifice of LAA was>1
cm. Because of concerns regarding safety, both patients un-
derwent LAA removal before ablation. Neither patient
developed LAA thrombus after LAA excision, and neither
developed thromboembolic events after surgery. One pa-
tient (1.1%) underwent conversion to median sternotomy
because of bleeding during right inferior pulmonary vein
dissection, early in our experience with this procedure. EP
testing was successfully performed in the latest 30 patients,
and all 30 patients achieved both entrance and exit block.
One patient (1.1%) developed acute cardiac dysfunction
caused by subendocardial infarction and recovered within
12 days. No patient died in the perioperative period. The
mean ventilator support time was 12.9  6.4 hours. The
mean hospitalization was 15.9  9.2 days. The mean
follow-up duration was 60.1  15.8 months. During the
follow-up period, 21 patients (23.1%) received direct cur-
rent cardioversion, 2 of them (2.2%) twice. At the latest
follow-up point, no patient required a vitamin K antagonist2176 The Journal of Thoracic and Cardiovascular Surfor anticoagulation. Of the 78 patients followed up for 5
years, 38 (48.7%) with AF recurrence (46.2%, 36 of 78)
or a CHADS2 score>2 points with NSR (2.6%, 2 of 78)
received aspirin therapy to prevent cerebrovascular events.
One patient (1.1%) experienced a postoperative stroke in 3
months after discharge (CHADS2 score, 5). Four patients
died of noncardiac disease during later follow-up.
Rhythm Results
During the 5-year period, 9 patients (9.9%) had changed
their telephone number and home address and thus could
not be contacted. In the present study, 63 of 91 patients
(69.2%) did not live in Beijing. It was difficult for the pa-
tients who lived at a distance to come and stay in Beijing
for several days to undergo Holter monitoring. We sug-
gested that all patients undergo 12-lead ECG examinations
at our center at each follow-up interval. Patients with AF or
any other arrhythmia on 12-lead ECG analysis were not
asked to undergo Holter analysis again. The Holter moni-
tors were only used for the patients with normal 12-lead
ECG findings. In all, 592 interviews were completed during
the follow-up period, and 445 Holter monitoring results
were recorded. The Holter monitor recording rate was
75.2% per patient.
At discharge, 66 of the 91 patients (72.5%) were in NSR,
21 (23.1%) were in AF, and 4 (4.4%) were AFL/AT. At the
3-month interval, 72 of the 91 patients (79.1%) were in
NSR. The proportion of patients in NSR was 85.4% (41
of 48) in those with PAF and 72.1% (31 of 43) in those
with non-PAF. At the 6-month interval, 73 of 90 patients
(81.1%) were in NSR: 44 of 47 (93.6%) with PAF and 29
of 43 (67.4%) with non-PAF. At the latest follow-up point,
the data were complete for 78 patients, and 43 (55.1%)
were in NSR: 27 of 39 (69.2%) with PAF and 16 of 39
(41.0%) with non-PAF. Overall, 40 of the 78 patients
(51.3%) were in sinus rhythm and not taking any antiar-
rhythmic drugs at 5 years postoperatively. In the present
study, no significant difference was found in the proportion
of patients in NSR between those who had undergone EP
testing and those who had not (63.3% vs 55.7%, P ¼ .7).
The outcomes of the rhythms were descriptively
analyzed at each interval during the 5-year follow-up period
(Figure 1).
Risk Factors for Later AF Recurrence
During the follow-up period, the primary endpoint was
the success rate of video-assisted PVI, defined as the
absence of any atrial arrhythmia recurrence lasting>30
seconds at the clinical visit and at ECG analysis or on the
long-term cardiac rhythm recording after discharge. We
classified all 91 patients into 2 groups according to the
occurrence of the primary endpoint events. The indepen-
dent risk factors for AF recurrence in these 2 groups were
compared (Table 2). The results showed that 6 risk factorsgery c November 2014
FIGURE 1. General review of heart rhythm at each postoperative period.
AFL/AT,Atrial flutter/atrial tachycardia; AF, atrial fibrillation;NSR, normal
sinus rhythm; AADs, antiarrhythmic drugs; N., number.
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tion, LVDd, LVEF, and LAD.
From the receiver operating characteristic curve analysis,
the preoperative LVEF, LAD, AF duration, and LVDd
were predictive of postoperative AF/AFL/AT recurrence
(Figure 2). The cutoff point for the LVEF was 64.5%,
with a sensitivity of 61.5% and specificity of 65.7%. The
area under the curve was estimated to be 0.69 (95% confi-
dence interval [CI] 0.57-0.80; P¼ .003). The optimal cutoff
point for the LAD was 44 mm, with a sensitivity of 92.1%
and specificity of 52.8%. The area under the curve was esti-
mated to be 0.77 (95% CI, 0.68-0.86; P<.001). The cutoff
point for preoperative AF duration was 31.5 months, with a
sensitivity of 84.2% and specificity of 60.4%. The area un-
der the curve was estimated to be 0.73 (95% CI, 0.63-0.83;
P<.001). The cutoff point for the LVDd was 45.7 mm, with
a sensitivity of 83.3% and specificity of 42.3% for predict-
ing postoperative AF/AFL/AT recurrence. The area under
the curve was estimated to be 0.62 (95% CI, 0.50-0.74;
P ¼ .062).
TABLE 2. Comparison of AF-related risk factors stratified by
primary endpoint
Factor
Primary endpoint reached
P valueYes (n ¼ 53) No (n ¼ 38)
Male gender 30 (56.6) 28 (73.7) .095
Age (y) 58.4  8.9 57.5  10.9 .684
Non-PAF 19 (35.8) 24 (63.2) .010
AF duration (mo) 44.7  49.3 74.0  52.5 .008
LVDd (mm) 47.1  4.9 49.5  5.9 .043
LVEF (%) 65.5  8.4 59.5  9.3 .002
LAD (mm) 44.9  10.1 55.6  9.2 <.001
BMI (kg/m2) 25.0  3.4 26.8  7.7 .119
EP testing performed 11 (20.8) 19 (50.0) .490
Data presented as n (%) or mean  standard deviation. PAF, Paroxysmal atrial fibril-
lation; LVDd, left ventricular end-diastolic dimension; LVEF, left ventricular ejection
fraction; LAD, left atrial dimension; BMI, body mass index; EP, electrophysiologic.
The Journal of Thoracic and CarWe divided all the patients into 2 groups according to the
cutoff points for the 4 risk factors and compared the per-
centage with postoperative NSR using Kaplan-Meier anal-
ysis (Figure 3). Statistically significant differences were
found in each group. We found that a preoperative LVEF
of 64.5%, LAD of 44 mm, AF duration of 31.5
months, LVDd of 45.7 mm, and the presence of non-
PAF were independent risk factors in our study.
We included these 5 variables in the Cox proportional
hazards model. The primary endpoint was AF recurrence,
and 38 patients experienced the primary endpoint. The re-
sults showed that an LAD of 44 mm (hazard ratio, 5.56;
95% CI, 1.68-18.387; P ¼ .005), AF duration of 31.5
months (hazard ratio, 3.67; 95% CI, 1.50-8.95; P ¼ .004)
were identified as independent risk factors on multivariate
analysis (Table 3).
DISCUSSION
The initial onset of AF could be related to the mostly
ectopic triggers limited to the PVs.15-17 However, as the AF
duration increases, the AF mechanisms could involve the
interaction of many factors. It has been well recognized that
the main factors that participate in the formation and
maintenance of AF include triggers limited to the PV, right
atrial trigger, autonomic ganglia plexus, and the reentry
cycle on the posterior wall of the left atrium.14 Thus, video-
assisted PVI alonewill not be suitable for all patientswithAF.
Although our long-term results have shown that the cure
rate of minimally invasive PVI alone has been relatively
low, it was still greater than the long-term results of single
catheter ablation, as recently reported. It was reported by
Sorgente and colleagues18 that the cure rate for single cath-
eter ablation was only 23% at 6 years of follow-up. Also,
for all the cases, the cure rate for paroxysmal AF was
36% and for persistent AF was only 15%.18 Catheter abla-
tion has been limited by its complications, such as PV ste-
nosis, thrombosis, and pericardial tamponade. It also has the
disadvantages of a long ‘‘learning curve’’ and poor repeat-
ability. Catheter ablation not only carries a high risk of
reoperation, but also increases patients’ economic and psy-
chological burden. It has also been demonstrated in a recent
double-center randomized clinical study of catheter abla-
tion and minimally invasive surgical ablation of atrial fibril-
lation that the overall cure rate for catheter ablation was
obviously lower than that of minimally invasive surgical
ablation during the same period (36.5% vs 65.6%,
P ¼ .0022).19 Minimally invasive PVI has shown more ad-
vantages than catheter ablation in some respects.
In the American Heart Association/European Society of
Cardiology AF management guidelines, AF has been clas-
sified into PAF, persistent AF, and longstanding, persistent
AF according to the preoperative duration of AF.11,20 At
present, the preoperative AF type has been accepted as an
essential index of whether the patient is suitable fordiovascular Surgery c Volume 148, Number 5 2177
FIGURE 2. Receiver operating characteristics curve showing the cutoff value for preoperative (A) left ventricular ejection fraction (LVEF), B, left atrial
diameter (LAD),C, atrial fibrillation (AF) history, and D, left ventricular end-diastolic dimension (LVDd) for atrial fibrillation/atrial flutter/atrial tachycardia
recurrence after video-assisted pulmonary vein isolation alone. AUC, Area under the curve.
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that the postoperative NSR rate of PVI alone was greater
for PAF, with a significantly lower NSR rate for persistent
AF.8,21,22 In our study, the average LAD was 49.4  11.0
mm. At 5 years of follow-up, the general NSR rate was
55.1% (43 of 78). The NSR rate for those with PAF and
non-PAF was 69.2% and 41.0%, respectively (P ¼ .01).
Our results have also shown that the long-term NSR rate
for those with PAF postoperatively was greater than that
for the non-PAF. As recently reported, using the Dallas
lesion and five-box lesion to add ablation lines on the basis
of PVI improved the NSR rate in those with persistent AF in
the early follow-up period.23-25 This might have resulted
from preventing the macroreentry from propagating by
adding ablation lines.26 The additional ablation lesions
were created for patients with LAF and a large preoperative
LAD and long AF duration later in our study period. The
initial results from our center showed that the cure rate
for this novel procedure for non-PAF was 75.0% at 1 year
of follow-up. Our results have also demonstrated that PVI
alone might not be sufficient for persistent AF.
However, the question remains whether all patients with
PAF are suitable for video-assisted PVI alone and whether2178 The Journal of Thoracic and Cardiovascular Surall patients with persistent AF are not suitable for video-
assisted PVI alone. In some studies, the risk factors that
could affect the postablation recurrence of AF also included
the preoperative LAD, ablation device, and energy
selection.27-30 The results of our study showed that a
preoperative AF duration of 31.5 months was another
independent risk factor for AF recurrence. A total of 53
patients had an AF duration of 31.5 months (47.2% with
PAF and 52.8% with non-PAF) and 38 had an AF duration
of<31.5 months (60.5% with PAF and 39.5% with non-
PAF). Our results have shown that the NSR of patients
with an AF duration of 31.5 months was significantly
lower than that of patients with an AF duration of<31.5
months (39.6% vs 84.2%; P< .001). When we included
the preoperative AF type, AF duration of 31.5 months,
non-PAF, and preoperative LVDd, LVEF, and LAD in the
Cox proportional hazards model, a preoperative AF duration
of 31.5 months and LAD were statistically significant,
with the LAD the most essential risk factor (hazard ratio,
5.56; 95% CI, 1.68-18.387; P ¼ .005). This might indicate
that the preoperative LAD is more sensitive than the preop-
erative AF duration for predicting the recurrence of AF post-
operatively. In addition, the average LAD of the patientsgery c November 2014
FIGURE 3. Kaplan-Meier postoperative atrial fibrillation (AF)-free survival between the patients with preoperative (A) left ventricular ejection fraction
(LVEF) of<64.5% versus64.5% (P ¼ .015); B, left atrial diameter (LAD) of<44 mm versus44 mm (P<.001); C, atrial fibrillation duration of<31.5
months versus 31.5 months (P<.001); and D, left ventricular end-diastolic dimension (LVDd) of<45.7 mm versus 45.7 mm (P ¼ .013).
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duration of<31.5 months was 52.8  10.9 mm and 44.6 
9.4mm (P<.001), respectively. This finding could also have
demonstrated that as the duration of AF increases, the left
atrium expands and affects the postoperative recurrence of
AF. These findings could also have resulted because as the
hemodynamics change (greater atrial pressure and wall
stress), the structural remodeling would be worse (fibrosis,
dilatation, and hypertrophy) in the left atrium,31 which couldTABLE 3. Hazard ratios for recurrence in Cox proportional hazards
model
Factor HR 95% CI P value
LAD 44 mm 5.56 1.68-18.39 .005
AF duration 31.5 mo 3.67 1.50-8.95 .004
HR, Hazard ratio; CI, confidence interval; LAD, left atrial diameter; AF, atrial fibril-
lation.
The Journal of Thoracic and Carlead to the facilitation of AF recurrence. As recently re-
ported, the occurrence of postoperative AFL/ATwas mainly
related to reentry around the ablation lines in the PVs, pos-
terior wall of the left atrium, and isthmus.32
Our study had several limitations. The small sample size
in our study might have limited the generalizability and
caused thewide range of CIs for the LAD in the multivariate
model. In the early stage of beginning this technique in our
clinic center, we lacked the device and technology for EP
testing; thus, two thirds of patients did not undergo EP
testing. Also, most of our patients did not live in Beijing,
and it was difficult for them to come and stay in Beijing
for several days to undergo Holter monitoring. We sug-
gested that all patients undergo 12-lead ECG examinations
at our center at each follow-up interval. The patients who
were in AF or had any other arrhythmia by the 12-lead
ECG analysis were not recommended to undergo Holterdiovascular Surgery c Volume 148, Number 5 2179
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those patients with normal 12-lead ECG findings. Thus,
our Holter monitoring results could not reflect the true situ-
ation. As a retrospective study, our study alsowas limited by
the lack of a comparison with catheter ablation or other sur-
gical energy sources and technologies.CONCLUSIONS
Our research has shown that the postoperative NSR rate
after video-assisted PVI alone would be low for patients
with AF and a larger LAD and long AF duration. The
LAD was the most important factor determining long-
term postoperative recurrence. In addition, for the patients
with a longer AF duration, the rate of recurrence was
greater, and video-assisted PVI alone should not be recom-
mended for those patients. In contrast, video-assisted PVI
alone could be considered for patients with a shorter AF
duration and a normal LAD. At present, we have performed
332 minimally invasive surgeries in our center. Additional
ablation lesions were created for the patients with LAF
and a large preoperative LAD and long AF duration in
our later study. The later results will be verified as our study
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